Pharma BD Deal Intelligence
OSI Pharmaceuticals Inc. / Gilead Sciences (oncology assets)
2001 · Acquisition/Merger · $200M · Complete
Announcement Sentiment
60
Positive
Asset purchase: $130M cash + $40M OSI stock + up to $30M milestones (NX211). Acquired Gilead's Boulder oncology pipeline/site. Up to $200M total.
Key facts
- Announced Jun 13, 2001
- Deal value $200M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals